Evaluation of the Spherical Flange Concept for a Rocket Engine

Due to the inherent tolerance variability of hardware, flange misalignments occur during installation of mating components for a liquid propellant rocket engine. Flange misalignments include axial, lateral, and angular offsets. If these misalignments are high, they can impart significant loads into the two mating components. These significant loads can then be a driver in the design of the propellant ducts. Such was the case for the Rocketdyne RS-83 engine design for the Space Launch Initiative Program. To address this flange misalignment issue, Marshall Space Flight Center joined with Rocketdyne to develop and test a spherical flange system that allows for misalignment, yet reduces loads imparted, and at the same time provides sufficient sealing against leakage. The flange design was tested to evaluate and compare performance parameters such as misalignment and leakage. The environmental conditions ranged from -100 to 400 degrees Fahrenheit (F) with 1000 to 4000 pounds per square inch gage (psig) pressure. The desirable design features will be extracted and synthesized into a new flange design concept. This paper will address the spherical flange design and the test results

Intravascular Talcosis due to Intravenous Drug Use Is an Underrecognized Cause of Pulmonary Hypertension

Intravenous injection of illegal drugs or medications meant for oral administration can cause granulomatous disease of the lung. This intravascular talcosis results in pulmonary fibrosis and pulmonary hypertension. Nine cases of histologically confirmed intravascular talcosis were reviewed with specific attention given to the clinical histories in these patients. Five autopsy cases were included in this series with detailed investigation in the anatomic features associated with intravascular talcosis and pulmonary hypertension. All nine patients showed perivascular and/or intravascular deposition of polarizable foreign material in their lungs. Intravascular talcosis as a result of previous intravenous drug use was not clinically suspected in any patient despite clinically diagnosed pulmonary hypertension in five. All patients showed dilatation of the right and left heart, but none had dilatation of the aortic valve. Congestive heart failure with hepatosplenomegaly was also common. We conclude that intravascular talcosis is an underdiagnosed cause of pulmonary hypertension in patients with known history of intravenous drug use

Detoxification of Outfall Water Using Natural Organic Matter

2010 S.C. Water Resources Conferences - Science and Policy Challenges for a Sustainable Futur

Animal Models of Hemophilia and Related Bleeding Disorders

Animal models of hemophilia and related diseases are important for development of novel treatments and to understand the pathophysiology of bleeding disorders in humans. Testing in animals with the equivalent human disorder provides informed estimates of doses and measures of efficacy, which aids in design of human trials. Many models of hemophilia A, hemophilia B, and von Willebrand disease have been developed from animals with spontaneous mutations (hemophilia A dogs, rats, sheep; hemophilia B dogs; and von Willebrand disease pigs and dogs), or by targeted gene disruption in mice to create hemophilia A, B, or VWD models. Animal models have been used to generate new insights into the pathophysiology of each bleeding disorder and also to perform pre-clinical assessments of standard protein replacement therapies as well as novel gene transfer technology. Both the differences between species and differences in underlying causative mutations must be considered in choosing the best animal for a specific scientific stud

Severe Hemophilia A in a Male Old English Sheep Dog with a C→T Transition that Created a Premature Stop Codon in Factor VIII

Animals with hemophilia are models for gene therapy, factor replacement, and inhibitor development in humans. We have actively sought dogs with severe hemophilia A that have novel factor VIII mutations unlike the previously described factor VIII intron 22 inversion. A male Old English Sheepdog with recurrent soft-tissue hemorrhage and hemarthrosis was diagnosed with severe hemophilia A (factor VIII activity less than 1% of normal). We purified genomic DNA from this dog and ruled out the common intron 22 inversion; we then sequenced all 26 exons. Comparing the results with the normal canine factor VIII sequence revealed a C→T transition in exon 12 of the factor VIII gene that created a premature stop codon at amino acid 577 in the A2 domain of the protein. In addition, 2 previously described polymorphisms that do not cause hemophilia were present at amino acids 909 and 1184. The hemophilia mutation creates a new TaqI site that facilitates rapid genotyping of affected offspring by PCR and restriction endonuclease analyses. This mutation is analogous to the previously described human factor VIII mutation at Arg583, which likewise is a CpG dinucleotide transition causing a premature stop codon in exon 12. Thus far, despite extensive treatment with factor VIII, this dog has not developed neutralizing antibodies (‘inhibitors’) to the protein. This novel mutation in a dog gives rise to severe hemophilia A analogous to a mutation seen in humans. This model will be useful for studies of the treatment of hemophilia

The CareFirst Patient-Centered Medical Home Program: Cost and Utilization Effects in Its First Three Years

Background Enhanced primary care models have diffused slowly and shown uneven results. Because their structural features are costly and challenging for small practices to implement, they offer modest rewards for improved performance, and improvement takes time. Objective To test whether a patient-centered medical home (PCMH) model that significantly rewarded cost savings and accommodated small primary care practices was associated with lower spending, fewer hospital admissions, and fewer emergency room visits. Design We compared medical care expenditures and utilization among adults who participated in the PCMH program to adults who did not participate. We computed difference-in-difference estimates using two-part multivariate generalized linear models for expenditures and negative binomial models for utilization. Control variables included patient demographics, county, chronic condition indicators, and illness severity. Participants A total of 1,433,297 adults aged 18–64 years, residing in Maryland, Virginia, and the District of Columbia, and insured by CareFirst for at least 3 consecutive months between 2010 and 2013. Intervention CareFirst implemented enhanced fee-for-service payments to the practices, offered a large retrospective bonus if annual cost and quality targets were exceeded, and provided information and care coordination support. Measures Outcomes were quarterly claims expenditures per member for all covered services, inpatient care, emergency care, and prescription drugs, and quarterly inpatient admissions and emergency room visits. Results By the third intervention year, annual adjusted total claims payments were $109 per participating member (95$192, −$27), or 2.8 % lower than before the program and compared to those who did not participate. Forty-two percent of the overall decline in spending was explained by lower inpatient care, emergency care, and prescription drug spending. Much of the reduction in inpatient and emergency spending was explained by lower utilization of services. Conclusions A PCMH model that does not require practices to make infrastructure investments and that rewards cost savings can reduce spending and utilization

Innovative Technologies And Vadose Zone Treatment Of Chlorinated Volatile Organic Compounds - Case Study

Over the last 10 years a mix of innovative and conventional characterization techniques has been used to assess the contamination of vadose zone sediments beneath the pilot-scale test facility known as TNX at the Savannah River Site (SRS) in South Carolina. Shallow soils and groundwater beneath the TNX facility are contaminated with chlorinated volatile organic compounds (CVOCs), trichloroethylene (TCE), carbon tetrachloride (CCl{sub 4}), perchloroethylene (PCE), and chloroform (CHCl{sub 3}). An interim pump and treat remediation system was placed in operation in 1996 to provide hydraulic containment of groundwater containing greater than 500 ug/L dissolved TCE. In 1994, a vadose zone study was initiated to determine the degree and extent of CVOC contamination above the contaminated groundwater. Headspace sampling and analysis, acoustic infrared spectroscopy, cone penetrometry, and vadose zone pumping tests were used to determine contaminant concentrations and physical properties related to soil vapor extraction. In 2001, soil vapor extraction (SVE), a presumptive remedy for CVOCs in soils similar to those present beneath TNX, was selected to treat the CVOC contamination. Cone Penetrometer Testing (CPT) with soil vapor sampling provided a detailed understanding of the subsurface geology and CVOC distribution which was essential for proper well design and placement. Twelve SVE wells were installed using direct push technology (DPT) and were tested to determine specific capacity and CVOC concentrations. This information was then used to develop a strategy for operating the SVE system. Based on the results of the baseline testing and previous studies, sets of 2 to 3 extraction wells will be treated using SVE at one month intervals. This will allow continuous operation of the SVE system and give individual wells up to 3 months for rebound between treatments. This method of operation is intended to maximize contaminant recovery from individual wells and reduce the overall capital investment and operating cost of the SVE system

Activism, affect, identification: trans documentary in France and Spain and its reception

This article explores the documentation of trans activism in France and Spain since the 2000s. The first part addresses questions surrounding the place of affect and narrative in documentary film, particularly in relation to trans issues. The second part o f the article analyses an audience case study from a screening at the International Gay and Lesbian Film Festival in Barcelona of Valérie Mitteaux's Girl or Boy, My Sex is not my Gender (2011), considering how different viewers respond to the representatio n of trans identities. The article builds on qualitative research whilst extending the exploration of sexuality and gender in previous audience studies to a consideration of documentary film, seeking to provide a more nuanced understanding of what audience claims for identification in politicised contexts mean

Banner News

https://openspace.dmacc.edu/banner_news/1336/thumbnail.jp

Banner News

https://openspace.dmacc.edu/banner_news/1333/thumbnail.jp